180 Life Sciences Corp.

NASDAQ: ATNF · Real-Time Price · USD
7.09
-0.52 (-6.83%)
At close: Aug 15, 2025, 3:59 PM
6.95
-1.97%
After-hours: Aug 15, 2025, 04:11 PM EDT

180 Life Sciences Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
4.59M 1.98M 6.97M 8.22M
Short-Term Investments
n/a n/a n/a n/a
Long-Term Investments
n/a n/a n/a n/a
Other Long-Term Assets
n/a n/a -15.66M -9.71M
Receivables
41.19K 279.04K 310.02K 80.78K
Inventory
n/a n/a n/a n/a
Other Current Assets
n/a 171.04K 310.95K 613.77K
Total Current Assets
5.14M 3.64M 8.93M 11.2M
Property-Plant & Equipment
n/a n/a n/a n/a
Goodwill & Intangibles
7.62M 1.62M 10.72M 51.51M
Total Long-Term Assets
7.62M 1.62M 10.72M 51.51M
Total Assets
12.76M 5.26M 19.65M 62.71M
Account Payables
1.93M 1.89M 1.8M 586.61K
Deferred Revenue
n/a n/a n/a 1.98M
Short-Term Debt
147.89K 1.03M 1.31M 1.91M
Other Current Liabilities
n/a 50.06K 200.64K 13.54M
Total Current Liabilities
3.5M 5.06M 5.66M 19.7M
Long-Term Debt
6.62K 19.94K 31.19K 48.16K
Other Long-Term Liabilities
n/a n/a 31.19B n/a
Total Long-Term Liabilities
6.62K 324.59K 2.65M 3.69M
Total Liabilities
3.51M 5.39M 8.31M 23.39M
Total Debt
154.5K 1.05M 1.34M 1.96M
Common Stock
318.00 54.00 375.00 3.4K
Retained Earnings
-141.52M -127.34M -107.41M -68.68M
Comprehensive Income
-2.92M -2.9M -2.89M 817.44K
Shareholders Equity
9.25M -127.73K 11.34M 39.32M
Total Investments
n/a n/a n/a n/a